ADIM
EXC icon

Alpha DNA Investment Management’s Exelon EXC Stock Holding History

Alpha DNA Investment Management’s Portfolio EXC Stock Details EXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-280
Closed -$8K – 278
2021
Q1 		$8K Hold
280
– – 0.01% 306
2020
Q4 		$8K Buy
+280
New +$8.26K 0.01% 317

Other funds holding EXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's EXC Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Exelon (EXC) in Q2 2021, closing a stake of 280 shares — an estimated $8K sold.

Alpha DNA Investment Management first reported a position in EXC in Q4 2020 and held it in 2 quarters. The position peaked at $8K in Q1 2021. 918 funds tracked by Wall St. Rank hold EXC as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Exelon position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 280 Exelon shares in Q2 2021, an estimated $8K.
  • Alpha DNA Investment Management first reported a position in Exelon in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Exelon position peaked at $8K in Q1 2021.
  • 918 funds tracked by Wall St. Rank held Exelon as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.